Robert Leo Murphy

  • 12778 Citations
1975 …2024
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1975 2019


Excess early mortality in HIV/hepatitis B virus co-infected patients initiating antiretroviral therapy in Kenya

Mbae, M., Owen, L., Elisha, K. K., Ndhere, A., Mugambi, N. S., Yogev, R., Murphy, R. L. & Jarvis, J. N., Jul 1 2019, In : AIDS. 33, 8, p. 1404-1406 3 p.

Research output: Contribution to journalLetter

Hepatitis B virus
4 Citations (Scopus)

Patient-selected treatment partners did not protect against drug resistance during first-line NNRTI-based HAART in a randomized trial

Taiwo, B. O., Idoko, J. A., Marcelin, A. G., Otoh, I., Reddy, S., Iyaji, P. G., Agbaji, O., Penugonda, S., Agaba, P. A. & Murphy, R. L., Aug 15 2010, In : Journal of Acquired Immune Deficiency Syndromes. 54, 5, p. 563-565 3 p.

Research output: Contribution to journalLetter

Viral Drug Resistance
HIV Reverse Transcriptase
Anti-HIV Agents
Highly Active Antiretroviral Therapy
Missense Mutation
4 Citations (Scopus)

A step ahead on the HIV collaboratory

Murphy, R. L., Autran, B., Katlama, C., Brucker, G., Debre, P., Calvez, V., Clotet, B., Clumeck, N., Costagliola, D., Deeks, S. G., Dorrell, L., Gatell, J., Haase, A., Klein, M., Lazzarin, A., McMichael, A. J., Papagno, L., Schacker, T., Wain-Hobson, S., Walker, B. D. & 1 others, Youle, M., Jan 1 2009, In : Science. 324, 5932, p. 1264-1265 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

How infrequent are opportunistic diseases and immune reconstitution syndromes among HIV-infected individuals who have favorable CD4+ cell count responses to antiretroviral therapy? [4] (multiple letters)

Phillips, P., Koletar, S. L., Williams, P. L., Wu, J., McCutchan, J. A., Cohn, S. E., Murphy, R. L., Lederman, H. M. & Currier, J. S., May 1 2005, In : Clinical Infectious Diseases. 40, 9, p. 1379-1381 3 p.

Research output: Contribution to journalLetter

AIDS-Related Opportunistic Infections
Immune Reconstitution Inflammatory Syndrome
Anti-HIV Agents
Immune System Diseases
Highly Active Antiretroviral Therapy
54 Citations (Scopus)

The impact of co-infection with hepatitis C virus and HIV on the tolerability of antiretroviral therapy

Melvin, D. C., Lee, J. K., Belsey, E., Arnold, J. & Murphy, R. L., Apr 13 2000, In : AIDS. 14, 4, p. 463-465 3 p.

Research output: Contribution to journalLetter

Anti-HIV Agents
Hepatitis C
Aspartate Aminotransferases
Alanine Transaminase

The reply

Clifford Lane, H., Polis, M. A., Murphy, R. L., Nussenblatt, R. B. & Masur, H., Jan 1 1995, In : The American Journal of Medicine. 98, 3, p. 317-318 2 p.

Research output: Contribution to journalLetter

8 Citations (Scopus)
Pneumocystis Infections
Pneumocystis Pneumonia
Cohort Studies
5 Citations (Scopus)

The diagnosis of nonmalignant diseases related to asbestos.

Murphy, R. L., Jan 1 1987, In : The American review of respiratory disease. 136, 6, p. 1516-1517 2 p.

Research output: Contribution to journalLetter

Thoracic Diseases
Medical Societies
24 Citations (Scopus)

Fansidar and hepatic granulomas

Lazar, H. P., Murphy, R. L. & Phair, J. P., Jan 1 1985, In : Annals of Internal Medicine. 102, 5, 1 p.

Research output: Contribution to journalLetter

Chemical and Drug Induced Liver Injury